Results 241 to 250 of about 561,196 (291)

The impacts of pricing and reimbursement policies on access to cell and gene therapies across Europe. [PDF]

J Community Genet
Han Y, Andreoletti M, Minssen T, Vayena E, Ormond KE.   +4 more
europepmc   +1 more source

From Kigali to Rio: advancing an evidence-based and equitable HIV response. [PDF]

J Int AIDS Soc
Grinsztejn B, Ochanda RM, Allinder SM, Janamnuaysook R, Grulich A, Ngure K, Road to Rio Advisory Group.   +6 more
europepmc   +1 more source

Changes in hospital financial performance and quality of care after real estate investment trust acquisition: quasi-experimental difference-in-differences study.

BMJ
Bruch JD, Ramesh T, Yu EB, Zheng J, Phelan J, Orav EJ, Tsai TC.   +6 more
europepmc   +1 more source

Pharmaceutical access in Brazil: challenges and opportunities. [PDF]

Global Health
Ruas CM, Portela R, de Assis Acurcio F, Alvares-Teodoro J, Guerra Júnior AA, Kesselheim AS.   +5 more
europepmc   +1 more source

Equitable access to costly new drugs.

BMJ
Woods B, Ten Ham R, Claxton K.
europepmc   +1 more source

Network centrality drives optimal protection investment against systemic risk propagation in complex systems. [PDF]

Sci Rep
Park C.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Economics of international investment agreements

Journal of International Economics, 2021
Abstract Nearly 2700 international investment agreements protect foreign investment against host country policies. This paper analyzes the design and implications of their contentious provisions regarding regulatory expropriations. It derives conditions under which “carve-out” compensation mechanisms, similar to those in actual agreements, solve ...
Henrik Horn, Thomas Tangerås
openaire   +1 more source